A carregar...

Benefit of Adjuvant Chemotherapy After Resection of Stage II (T1-2N1M0) Non-Small Cell Lung Cancer in Elderly Patients

BACKGROUND: We evaluated the use and efficacy of adjuvant chemotherapy after resection of T1-2N1M0 non-small cell lung cancer (NSCLC) in elderly patients. METHODS: Factors associated with the use of adjuvant chemotherapy in patients older than 65 years of age who underwent surgical resection of T1-2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Main Authors: Berry, Mark F., Coleman, Brooke K., Curtis, Lesley H., Worni, Mathias, D’Amico, Thomas A., Akushevich, Igor
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4297230/
https://ncbi.nlm.nih.gov/pubmed/25192680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-4056-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!